Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 12, 2023

BUY
$0.21 - $0.35 $6,529 - $10,882
31,093 Added 151.78%
51,579 $11,000
Q4 2022

Jan 18, 2023

BUY
$0.22 - $8.4 $4,506 - $172,082
20,486 New
20,486 $0
Q2 2021

Jul 23, 2021

SELL
$2.6 - $3.65 $10,171 - $14,278
-3,912 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$2.73 - $4.5 $4,575 - $7,542
1,676 Added 74.96%
3,912 $13,000
Q4 2020

Jan 14, 2021

BUY
$2.6 - $3.32 $5,813 - $7,423
2,236 New
2,236 $5,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $356M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.